{"id":"NCT03317444","sponsor":"Tricida, Inc.","briefTitle":"Evaluation of TRC101 in Subjects With Metabolic Acidosis Associated With Chronic Kidney Disease","officialTitle":"A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TRC101 in Subjects With Chronic Kidney Disease and Metabolic Acidosis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-09-26","primaryCompletion":"2018-05-04","completion":"2018-05-15","firstPosted":"2017-10-23","resultsPosted":"2021-04-26","lastUpdate":"2021-04-26"},"enrollment":217,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Metabolic Acidosis"],"interventions":[{"type":"DRUG","name":"TRC101","otherNames":["Veverimer"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"TRC101","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This is a multicenter, double-blind, placebo-controlled, parallel-design study. The study will enroll approximately 210 adult male and female subjects with stage 3 or 4 chronic kidney disease and metabolic acidosis. The study dosing (TRC101 or placebo) will continue for 12 weeks once daily.\n\nThe maximum study duration is anticipated to be up to 16 weeks.","primaryOutcome":{"measure":"Subjects With Change From Baseline in Serum Bicarbonate of â‰¥ 4 mEq/L or Serum Bicarbonate Within the Normal Range","timeFrame":"Baseline to Week 12","effectByArm":[{"arm":"TRC101 Treatment Arm","deltaMin":59.2,"sd":null},{"arm":"Placebo Treatment Arm","deltaMin":22.5,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"< 0.0001"},{"comp":"OG000 vs OG001","p":"< 0.0001"},{"comp":"OG000 vs OG001","p":"< 0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":10},"locations":{"siteCount":44,"countries":["United States","Bulgaria","Croatia","Georgia","Hungary","Serbia","Slovenia","Ukraine"]},"refs":{"pmids":["30857647"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":124},"commonTop":["Hyperkalaemia","Diarrhoea","Headache"]}}